Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Androgen-mediated Pathways in the Regulation of Insulin Sensitivity in Men
NCT01686828Phase 2Completed
- Sponsor
- University of Washington
- Start
- Jun 2013
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Testosterone TEPI patch in insulin resistance (IR) and androgen deficiency (4 arms), sponsored by University of Washington. Primary endpoint: Insulin Sensitivity Quantified by Matsuda Index at 4 weeks. Started Jun 2013; status: completed.
02
Drugs
Testosterone TEPI patch
03
Conditions
insulin resistance (IR)androgen deficiency
Beyond the preview
Go deeper on NCT01686828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01686828.